Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 11.1B | 10.5B | 10.3B | 9.9B |
Cost of revenue | 9.9B | 9.4B | 9.2B | 8.7B |
Gross profit | 1.3B | 1.1B | 1.2B | 1.2B |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | 774M | 665M | 676M | 691M |
Other operating expenses | 25M | 20M | -1M | 43M |
Operating income | 433M | 380M | 467M | 434M |
Non operating interest income | ||||
Income | — | — | — | — |
Expense | 43M | 34M | 29M | 28M |
Other income expense | — | — | — | — |
Pretax income | 390M | 346M | 438M | 406M |
Tax provision | 92M | 95M | 112M | 105M |
Net income | 298M | 251M | 326M | 301M |
Basic EPS | 5.5 | 4.5 | 5.7 | 5.1 |
Diluted EPS | 5.5 | 4.4 | 5.7 | 5.1 |
Basic average shares | 54.6M | 56M | 57M | 59M |
Diluted average shares | 54.8M | 56.5M | 57.7M | 59M |
EBITDA | 481M | 428M | 514M | 480M |
Net income from continuing op. | 298M | 251M | 326M | 301M |
Minority interests | — | — | — | — |
Preferred stock dividends | — | — | — | — |